Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
26%
OVERLAP
BY WEIGHT
3
# OF OVERLAPPING
HOLDINGS
PPH
27
HOLDINGS
13%
ALSO IN OZEM
OZEM
21
HOLDINGS
14%
ALSO IN PPH
SECTOR DRIFT (PPH minus OZEM)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PPH |
Weight in OZEM |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 23.2% | 15.8% | 15.8% |
 |
NOVO-NORDISK A/S-SPONS ADR | 5.4% | 11.9% | 5.4% |
|
PFIZER INC | 5.1% | 8.4% | 5.1% |
PPH Overweight Relative to OZEM
|
MERCK & CO. INC. | 12.6% |
|
ELI LILLY & CO | 7.4% |
 |
TEVA PHARMACEUTICAL-SP ADR | 4.6% |
|
MCKESSON CORP | 4.6% |
|
BRISTOL-MYERS SQUIBB CO | 4.5% |
|
CENCORA INC | 4.2% |
 |
GLAXOSMITHKLINE PLC-SPON ADR | 4.2% |
|
ASTRAZENECA PLC-SPONS ADR | 3.8% |
|
ABBVIE INC | 3.7% |
 |
NOVARTIS AG-ADR | 3.7% |
PPH Underweight Relative to OZEM
|
NOVO-NORDISK A/S-SPONS ADR | -6.5% |
|
KAILERA THERAPEUTICS INC | -5.9% |
 |
ASCLETIS PHARMA, INC. | -5.4% |
 |
CHINA PHARMACEUTICAL GROUP | -5.2% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -5.1% |
|
AMGEN INC | -4.9% |
|
VIKING THERAPEUTICS, INC. | -4.6% |
|
ASTRAZENECA PLC | -4.5% |
 |
HANMI PHARM CO LTD | -3.6% |
|
ZEALAND PHARMA A/S | -3.5% |